Akebia Therapeutics
AKBA
AKBA
150 hedge funds and large institutions have $334M invested in Akebia Therapeutics in 2019 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 44 increasing their positions, 44 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2.05% less ownership
Funds ownership: 73.76% → 71.7% (-2.1%)
21% less capital invested
Capital invested by funds: $421M → $334M (-$86.5M)
Holders
150
Holding in Top 10
–
Calls
$19.3M
Puts
$468K
Top Buyers
| 1 | +$1.49M | |
| 2 | +$1.38M | |
| 3 | +$1.16M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.11M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.05M |
Top Sellers
| 1 | -$8.44M | |
| 2 | -$2.23M | |
| 3 | -$855K | |
| 4 |
Morgan Stanley
New York
|
-$740K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$738K |